Skip to content

Selective Control Assessment of the Lower Extremities to probe the increased metabolic cost of walking after Stroke

Selective Control Assessment of the Lower Extremities to probe the increased metabolic cost of walking after Stroke - SCALEStroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53894
Enrollment
36
Registered
2023-03-22
Start date
2023-04-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke and CVA

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Individuals post stroke (n = 12) - Diagnosis of stroke at least 6 months prior to testing. - Age between 18 and 75 years old. - Able to walk independently for a minimum of 6 minutes without an assistive device, manual assistance or walking aids. - Paresis on one side of the body (hemiparesis). Able-bodied young adults (n = 12) - Age between 18 and 25 years old. Able- bodied older adults (n = 12) - Age between 50 and 75 years old.

Exclusion criteria

Exclusion criteria: Individuals post stroke (n = 12) - Unable to understand the study instructions in Dutch. - Unable to execute the study instructions. - Having received a botulinum toxin injection in the lower extremities within 12 weeks prior to testing. - Indications of orthopaedic, neurological, cardiorespiratory and behavioral conditions other than stroke that may affect gait. Healthy young and older adults (2 x n = 12) - Unable to understand the study instructions in Dutch. - Indications of orthopaedic, neurological, cardiorespiratory and behavioral conditions that may affect gait.

Design outcomes

Primary

MeasureTime frame
Muscle co-activation measured by surface electromyography (Delsys 16-channel sEMG system, Natick, MA, USA) and energy cost measured by breath-to-breath analysis (K5, Cosmed, Rome, IT).

Secondary

MeasureTime frame
Kinematic description of the movements measured with a 10-camera motion capture system (Vicon Motion Systems Ltd, Yarnton, UK).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026